.png)
ANALYSIS OF CHEMOTHERAPY COSTS IN BREAST CANCER PATIENTS PARTICIPATING BPJS AT DHARMAIS CANCER HOSPITAL JAKARTA
Abstract
This study aims to find out how much chemotherapy costs for inpatient breast cancer chemotherapy patients participating in BPJS and whether there is a difference in real hospital costs compared to INA-CBGs rates. This research is a descriptive, observational study taken from secondary data, in the form of medical record data, laboratory data, INA-CBGs e-claim data and financial data on patient medical costs in accordance with the inclusion and exclusion criteria totaling 100 patient data. Data analysis uses One Sample T-test to see whether there is a significant difference between real costs and INA-CBGs rates. Based on the results of the One Sample T-test, it shows that there is a significant difference. According to the statistical results, a significance of p<0.005 was obtained in class 3 and there was no significant difference in class 1 or class 2. The average cost that breast cancer patients have to pay for each procedure chemotherapy, severity level I Rp. 7,129,348, severity level II Rp. 9,323,275 and severity level III Rp. 9,037,426.
Keywords
Full Text:
PDFReferences
Abdullah, A. S. (2019). Analysis of Factors Causing Fraud Incidents Resulting from Upcoding Health Service Costs to BPJS Health Ambon Branch. Yamasi Makassar Health Journal, 3(1), 1–5.
Aisyah, N., Aryzki, S., Wahyuni, A., Andayani, T. M., & Puspandari, D. A. (2019). Factors that influence the real costs of breast cancer chemotherapy patients participating in JKN at Ulin Hospital, Banjarmasin. Journal Of Current Pharmaceutical Sciences, 2(2), 154–159.
Aisyah, N., Syarifuddin, A., Amami, P., & Mardiana, M. (2020). ANALYSIS OF CHEMOTHERAPY COSTS FOR BREAST CANCER AND CERVICAL CANCER PATIENTS AT ULIN HOSPITAL BANJARMASIN. Indonesian Pharmaceutical Human Journal, 3(1), 19– 28. https://doi.org/10.36387/jifi.v3i1.500
Bray F, Ferlay J, Soerjomatram I, Siegel RL, Torre LA, & Jemal A. (2018). GLOBOCAN Estimates of Worldwide Incidence and Mortality for 36 Cancers in 185 Countries. Global Cacer Statistics, 394–424.
Dipiro, J. T. (2014). Pharmacotherapy: A Pathophysiologic Approach (9th ed., Vol.2). McGrawHill Education.
Hermawan, D., & Djamaludin, D. (2016). The incidence of breast cancer is seen from the factors of age, early menstruation and use of contraception. Holistic Health (The Journal of Holistic Healthcare), 10(2), 45–53.
Musnelina, L., Pontoan, J., & Martin, C. J. (2019). ANALYSIS OF THE COST EFFECTIVENESS OF CHEMOTHERAPY IN BREAST CANCER PATIENTS AT GATOT SOEBROTO RSPAD, JAKARTA. Scientific Manuntung, 5(1), 65–72.
Riadinata, & Pratiwi F. (2016). Analysis of Mother's Knowledge Level about Breast Cancer with Awareness Behavior in Housewives. Journal of Obstetrics, 153–161.
Santoso, A., Sulistyaningrum, I. H., Rosyid, A., Cahyono, E. B., Wirastuti, K., & Riyanto, B. (2020). Comparison of Real Costs with INA-CBGs Rates for Breast Cancer in the Era of National Health Insurance. Journal of Scientific and Practical Pharmacy (JFSP), 6(1), 60–66.
Sari, R. P. (2014). Comparison of Real Costs with INA-CBGs Package Rates and Analysis of Factors Affecting Real Costs in Jamkesmas Inpatient Diabetes Mellitus Patients at Dr. Sardjito General Hospital, Yogyakarta. Spread Journal, 4(1), 61–70.
Sari S L, Indra R L, & Lestari R F. (2019). 'Correlation of Perceptions About the Side Effects of Chemotherapy with the Quality of Life of Breast Cancer Patients Shanti Lesmana Sari, Rani Lisa Indra, Raja Fitriana Lestari.' Jurnal Cakrawala Promkes, 1(2), 40–47.
Wahyuni, S., Saputra, I., & Hanum, F. (2019). Comparison of Real Hospital Costs with INA-CBGs Rates for Thalassemia Sufferers at the Zainoel Abidin Agency Aceh General Hospital in 2018. Nanggroe Medika Medical Journal, 2(3), 8–16.
Wulandari, A., Monalisa, S., & Zaini, J. (2019). Cost Analysis of First Line Chemotherapy for Lung Cancer Patients at Persahabatan Hospital, East Jakarta for the 2016 Period. Sainstech Farma, 12(2), 85–92.
Youlden DR, Cramb SM, Yip CH, & Baade PD. (2014). Incidence and Mortality of Female Breast Cancer in the Asia-Pacific Region. . Cancer Biol Med, 101–115.
DOI: https://doi.org/10.52447/scpij.v10i2.7773
Refbacks
- There are currently no refbacks.